March 14, 2012 -- Bayer Healthcare’s long term sales goal is to triple its 2010 China revenues by 2015, bringing them up to $3.3 billion. Bayer is already one of the top five pharmas in China. To accomplish its goals in China, Bayer employed an audacious strategy for a big pharma: it transferred global authority for its primary care business from Berlin to Beijing. More details....
